[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Publications found: 33,057
Sort by:

Ischemic Heart Disease Drugs-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... profit status of Ischemic Heart Disease Drugs, and marketing status Market growth drivers and challenges The report segments the United States Ischemic Heart Disease Drugs market as: United States Ischemic Heart Disease Drugs Market: Regional Segment ...

January 2018 151 pages

Omega 3 Products-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... India Southeast Asia Australia Asia Pacific Omega 3 Products Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023): Omega 3 Omega-D3 Omega 3-6-9 Asia Pacific Omega 3 Products Market: Application Segment ...

January 2018 142 pages

Omega 3 Products-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Omega 3 Products market Market status and development trend of Omega 3 Products by types and applications Cost and profit status of Omega 3 Products, and marketing status Market growth drivers and challenges The report segments the China Omega 3 Products market as: China Omega 3 Products Market ...

January 2018 152 pages

Omega 3 Products-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Omega 3 Products-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Omega 3 Products industry, standing on the readers’ perspective, delivering detailed market data and ...

January 2018 147 pages

Omega 3 Products-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Omega 3 Products market Market status and development trend of Omega 3 Products by types and applications Cost and profit status of Omega 3 Products, and marketing status Market growth drivers and challenges The report segments the Europe Omega 3 Products market as: Europe Omega 3 Products Market ...

January 2018 159 pages

Omega 3 Products-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Omega 3 Products-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Omega 3 Products industry, standing on the readers’ perspective, delivering detailed market data in Global ...

January 2018 132 pages

Omega 3 Products-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary Omega 3 Products-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Omega 3 Products industry, standing on the readers’ perspective, delivering detailed market data and ...

January 2018 132 pages

Omega 3 Products-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... Omega 3 Products market Market status and development trend of Omega 3 Products by types and applications Cost and profit status of Omega 3 Products, and marketing status Market growth drivers and challenges The report segments the India Omega 3 Products market as: India Omega 3 Products Market ...

January 2018 148 pages

Omega 3 Products-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... North America Omega 3 Products market as: North America Omega 3 Products Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023): United States Canada Mexico North America Omega 3 Products Market: Product ...

January 2018 155 pages

Omega 3 Products-South America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Venezuela Colombia Others South America Omega 3 Products Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023): Omega 3 Omega-D3 Omega 3-6-9 South America Omega 3 Products Market: Application Segment ...

January 2018 134 pages

Omega 3 Products-United States Market Status and Trend Report 2013-2023

US$ 3,480.00

... The South Southwest United States Omega 3 Products Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023): Omega 3 Omega-D3 Omega 3-6-9 United States Omega 3 Products Market: Application Segment ...

January 2018 145 pages

Global Vitamin Industry Market Research 2017

US$ 2,600.00

... of the Vitamin market? 9. What are the Vitamin market challenges to market growth? 10. What are the Vitamin market opportunities and threats faced by the vendors in the global Vitamin market? Objective of Studies ...

January 2018 154 pages

North America Pharmaceutical Autoclaves Market by Manufacturers, Countries, Type and Application, Forecast to 2022

US$ 4,480.00

... to deeply display the North America Pharmaceutical Autoclaves market. Chapter 1, to describe Pharmaceutical Autoclaves Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter ...

January 2018 120 pages

Fibromyalgia - Pipeline Review, H1 2018

US$ 2,000.00

... . The Fibromyalgia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Fibromyalgia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

January 2018 68 pages

Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) - Pipeline Review, H1 2018

US$ 3,500.00

... being developed by Companies/Universities. It also reviews key players involved in Nuclear Receptor ROR Gamma (Nuclear Receptor RZR Gamma or Nuclear Receptor Subfamily 1 Group F Member 3 or RAR Related Orphan Receptor C or Retinoid Related Orphan Receptor Gamma or RORC) targeted therapeutics development with ...

January 2018 96 pages

Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018

US$ 3,500.00

... Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 83 pages

Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) - Pipeline Review, H1 2018

US$ 3,500.00

... Integrin Alpha 4 (CD49 Antigen Like Family Member D or VLA4 Subunit Alpha or CD49d or ITGA4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 75 pages

P2X Purinoceptor 3 (P2RX3) - Pipeline Review, H1 2018

US$ 3,500.00

... P2X Purinoceptor 3 (P2RX3) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 53 pages

Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) - Pipeline Review, H1 2018

US$ 3,500.00

... Integrin Beta 7 (Gut Homing Receptor Beta Subunit or ITGB7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 55 pages

P2X Purinoceptor 7 (P2Z Receptor or P2RX7) - Pipeline Review, H1 2018

US$ 3,500.00

... P2X Purinoceptor 7 (P2Z Receptor or P2RX7) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 34 pages

72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding 72 kDa Type IV Collagenase (Matrix Metalloproteinase 2 or Gelatinase A or Neutrophil Gelatinase or 72 kDa Gelatinase or TBE 1 or MMP2 or EC 3.4.24.24) development landscape Develop ...

January 2018 33 pages

Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) - Pipeline Review, H1 2018

US$ 3,500.00

... Bcl 2 Like Protein 1 (Apoptosis Regulator BclX or BCLX or BCL2L1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 53 pages

Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) - Pipeline Review, H1 2018

US$ 3,500.00

... and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Cathepsin K (Cathepsin O or Cathepsin O2 or Cathepsin X or CTSK or EC 3.4.22.38) development landscape Develop and design in-licensing and ...

January 2018 39 pages

Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2018

US$ 3,500.00

... Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 41 pages

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) - Pipeline Review, H1 2018

US$ 3,500.00

... Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 74 pages

Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 (Bcl 2 Like Protein 3 or Bcl 2 Related Protein EAT/Mcl1 or BCL2L3 or MCL1) development landscape Develop and ...

January 2018 65 pages

Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) - Pipeline Review, H1 2018

US$ 3,500.00

... Intercellular Adhesion Molecule 1 (Major Group Rhinovirus Receptor or CD54 or ICAM1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 44 pages

Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Pipeline Review, H1 2018

US$ 3,500.00

... Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 35 pages

Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) - Pipeline Review, H1 2018

US$ 3,500.00

... Metabotropic Glutamate Receptor 4 (GPRC1D or MGLUR4 or GRM4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

January 2018 39 pages

Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD227 or MUC1) - Pipeline Review, H1 2018

US$ 3,500.00

... reviews Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD227 or MUC1) targeted therapeutics under development ...

January 2018 86 pages

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2018

US$ 3,500.00

... also reviews key players involved in Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) targeted therapeutics development with respective active and dormant ...

January 2018 77 pages

Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) - Pipeline Review, H1 2018

US$ 3,500.00

... key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 1A (Tumor Necrosis Factor Receptor 1 or Tumor Necrosis Factor Receptor Type I or p55 or p60 or CD120a or TNFRSF1A) development ...

January 2018 40 pages

Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H1 2018

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) development landscape Develop and ...

January 2018 80 pages

Europe Digestive System Drug Industry Situation and Prospects Research report

US$ 3,300.00

... of making you deeply understand the Digestive System Drug industry and meeting you needs to the report contents, Europe Digestive System Drug Industry Situation and Prospects Research ...

January 2018 139 pages

2017-2022 North America Enteric Empty Capsules Market Report

US$ 4,660.00

... will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Enteric Empty Capsules in North America market, especially in United States, ... splits North America into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

January 2018 119 pages

2017-2022 Global Top Countries Enteric Empty Capsules Market Report

US$ 4,960.00

... USD, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Enteric Empty Capsules in Global market, especially ... , Middle East and Africa, focuses on the top Players in each country, covering Capsugel CapsCanada Suheung Qualicaps Anhui Huangshan Capsule Shangxi ...

January 2018 119 pages

2017 Top 5 Enteric Empty Capsules Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa

US$ 4,960.00

... on the top 5 Enteric Empty Capsules players in each region, with sales, price, revenue and market share from 2012 to 2017, the top players ... , this report focuses on sales, market share and growth rate of Enteric Empty Capsules in each application, can be divided into Pharmaceutical Health Supplements ...

January 2018 119 pages

2017-2022 Europe Top Countries Enteric Empty Capsules Market Report

US$ 4,660.00

... 2016 and 2022. This report studies Enteric Empty Capsules in Europe market, especially in Germany, UK, France, Italy, Russia, Benelux, Turkey and other countries in Europe, focuses ...

January 2018 119 pages

2017-2022 United States Enteric Empty Capsules Market Report (Status and Outlook)

US$ 3,360.00

... , the Enteric Empty Capsules market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In United States market, the ...

January 2018 119 pages

2017-2022 India Enteric Empty Capsules Market Report (Status and Outlook)

US$ 3,360.00

... Enteric Empty Capsules market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In India ... market, the top players include Capsugel CapsCanada Suheung Qualicaps Anhui Huangshan Capsule Shangxi GS Capsule Qingdao Yiqing ...

January 2018 119 pages

2017-2022 China Enteric Empty Capsules Market Report (Status and Outlook)

US$ 3,360.00

... the Enteric Empty Capsules market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, ... the top players include Capsugel CapsCanada Suheung Qualicaps Anhui Huangshan Capsule Shangxi GS Capsule Qingdao ...

January 2018 119 pages

2017-2022 Asia-Pacific Top Countries Enteric Empty Capsules Market Report

US$ 4,660.00

... xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Enteric Empty Capsules in Asia-Pacific market, especially in China ... Countries, this report splits Asia-Pacific into several key Countries, with sales, revenue, market share of top players in these Countries, from 2012 to 2017 ...

January 2018 119 pages

Adult Vaccines-Asia Pacific Market Status and Trend Report 2013-2023

US$ 3,480.00

... Adult Vaccines market Market status and development trend of Adult Vaccines by types and applications Cost and profit status of Adult Vaccines, and marketing status Market growth drivers and challenges The report segments the Asia Pacific Adult Vaccines market as: Asia Pacific Adult Vaccines Market ...

January 2018 136 pages

Adult Vaccines-China Market Status and Trend Report 2013-2023

US$ 2,980.00

... Adult Vaccines market Market status and development trend of Adult Vaccines by types and applications Cost and profit status of Adult Vaccines, and marketing status Market growth drivers and challenges The report segments the China Adult Vaccines market as: China Adult Vaccines Market ...

January 2018 130 pages

Adult Vaccines-EMEA Market Status and Trend Report 2013-2023

US$ 3,480.00

Report Summary Adult Vaccines-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Adult Vaccines industry, standing on the readers’ perspective, delivering detailed market data and ...

January 2018 132 pages

Adult Vaccines-Europe Market Status and Trend Report 2013-2023

US$ 3,480.00

... Adult Vaccines market Market status and development trend of Adult Vaccines by types and applications Cost and profit status of Adult Vaccines, and marketing status Market growth drivers and challenges The report segments the Europe Adult Vaccines market as: Europe Adult Vaccines Market ...

January 2018 144 pages

Adult Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data

US$ 3,680.00

... Adult Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Adult Vaccines industry, standing on the readers’ perspective, delivering detailed market data in Global ...

January 2018 149 pages

Adult Vaccines-Global Market Status and Trend Report 2013-2023

US$ 2,480.00

Report Summary Adult Vaccines-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Adult Vaccines industry, standing on the readers’ perspective, delivering detailed market data and ...

January 2018 137 pages

Adult Vaccines-India Market Status and Trend Report 2013-2023

US$ 2,980.00

... Adult Vaccines market Market status and development trend of Adult Vaccines by types and applications Cost and profit status of Adult Vaccines, and marketing status Market growth drivers and challenges The report segments the India Adult Vaccines market as: India Adult Vaccines Market ...

January 2018 136 pages

Adult Vaccines-North America Market Status and Trend Report 2013-2023

US$ 3,480.00

... Adult Vaccines market Market status and development trend of Adult Vaccines by types and applications Cost and profit status of Adult Vaccines, and marketing status Market growth drivers and challenges The report segments the North America Adult Vaccines market as: North America Adult Vaccines Market ...

January 2018 160 pages

Filters

Search

Categories

23,521
914
8,559
40
23

Publishers

72
1
6
4
18
50
16
3
112
292
33
30
34
6,128
163
13
120
12
142
51
363
8
25
84
36
7
8
14
6
49
113
7
1
1,818
10
579
11
2,786
7
24
5,307
44
31
54
216
1,098
40
32
7
37
46
43
50
2,538
208
40
26
7
6
2
4
32
15
606
3,346
2,222
11
22
1
16
38
228
2
7
10
4
79
4
26
50
1
5
6
2
2
32
2
13
17
1
11
107
36
1
18
195
172
6
4
2
1
5
4
9
1
72
12
27
50
33
1
27
27
1
2
1
42
55
14
18
1
323
954
555
2
1
2
5
88
72
59
37
41
22
2
14
5
23
2
2

Regions

14
13
12
11
8
7
6
3
3
2
2
1
4
7
19
8
1,367
101
83
57
51
50
48
34
28
27
26
25
25
22
22
21
20
19
19
19
19
19
19
19
19
18
18
18
18
17
17
16
16
16
16
16
16
16
16
15
15
14
13
13
12
12
11
11
11
11
11
10
10
8
7
5
1,703
741
22
20
14
1,325
701
597
31
30
7
6
6
5
5
4
5
5
5
4
3
1
1
1
1
25
4
11
2
2
2
2
693
7
13
10
6
46
12
6
57
4
24,205

Price

Date

Pages

Offers

16
16
10
44
5
1
2